Search results
Results from the WOW.Com Content Network
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons. [10] In August 2019, Globus Medical acquired privately-owned StelKast, manufacturer of implants and instruments for hip and knee replacement. [11] In February 2023, Globus Medical acquired NuVasive in an all-stock ...
Globus Medical (NYSE: GMED) Q3 2024 Earnings Call Nov 05, 2024, 4:30 p.m. ET. ... an increase of 39% versus prior year. Q3 was the highest number of unit placements since launch, growing 50% over ...
Image source: The Motley Fool. Globus Medical (NYSE: GMED) Q2 2024 Earnings Call Aug 06, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
For premium support please call: 800-290-4726 more ways to reach us
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Glassdoor also puts the conclusions of its research of other companies towards its company policies. [10] In 2015, Tom Lakin produced the first study of Glassdoor in the United Kingdom, concluding that Glassdoor is regarded by users as a more trustworthy source of information than career guides or official company documents. [31] [32]
David C. Paul (born 1966/1967) is an American billionaire businessman and the founder and executive chairman of Globus Medical, a medical device manufacturer. [ 1 ] As of February 2024, his net worth was estimated at US$1.4 billion.
NuVasive, Inc. is a medical devices company based in San Diego, California. Founded in 1997, it primarily develops medical devices and procedures for minimally invasive spine surgery . NuVasive's products include software systems for surgical planning and monitoring, access instruments, and implantable hardware.